Hospitals

PharmaLink Launches a DSCSA Compliant Solution for Retail and Hospital Markets

LARGO, FL / ACCESSWIRE / October 2, 2023 / PharmaLink announces a comprehensive suite of Drug Supply Chain Security Act…

10 months ago

Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients…

10 months ago

Vivimu Unveils Groundbreaking Compassionate Care Initiative: A 1 Billion MG Hemp-Derived Cannabinoid Giveaway Program

GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- In a bold move to democratize access to quality hemp-derived products, Vivimu.com…

10 months ago

BioStem Technologies: CMS Decision a “Win For Patients”

POMPANO BEACH, FL / ACCESSWIRE / September 29, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company…

10 months ago

TOMI Rolls Out New Innovative Disinfection Products to Support Its Expanding Customer Base

FREDERICK, Md., Sept. 29, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

10 months ago

Cloud DX Wins Competitive RFP, Signs Contract with Alberta Health Services

Cloud DX can now deliver digital Remote Patient Monitoring (dRPM) solutions to clients via Hospitals and via the Central Zone…

10 months ago

Etiometry Joins Forces with SRHO to Enable AI-based Decision Support in High-acuity Hospital Units across the U.S.

Partnership aims to improve outcomes and drive cost efficiencies within critical care units of SRHO - The National Organization member…

10 months ago

Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital

Continues SRT-100+™ customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancersBOCA RATON, Fla. , Sept.…

10 months ago

GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564

Collaboration sets stage for GigaGen’s first oncology asset to enter clinical development GIGA-564 is a differentiated anti-CTLA4 antibody with potential…

10 months ago

Cocrystal Pharma Doses First Subjects in Clinical Study of CDI-988 For Pandemic Norovirus and Coronavirus

BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), announces dosing of…

10 months ago